Skip to main content
All Posts By

Jeremy Klein

DCRI Receives Top Customer Loyalty Scores in ISR’s 6th Annual CRO Quality Benchmarking Study Press

DCRI Receives Top Customer Loyalty Scores in ISR’s 6th Annual CRO Quality Benchmarking Study

Informing the Pharmaceutical Drug Development and Commercialization Industry. Cary, N.C. – March 19, 2014 – Industry Standard Research (ISR) is announcing the launch of its 6th annual CRO Quality Benchmarking series with today's release of its "CRO Quality Benchmarking - Phase II/III…
Jeremy Klein
New ISR Report Provides Insight into CMO Service Quality, DSM among the Top 3 in Each Attribute Category Press

New ISR Report Provides Insight into CMO Service Quality, DSM among the Top 3 in Each Attribute Category

Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – March 12, 2014 – Industry Standard Research (ISR) today announced the availability of a new report titled “Contract Manufacturer Quality Benchmarking (2014),” providing a comprehensive assessment of CMO service…
Jeremy Klein
New ISR Report Uncovers Significant Clinical Development Activity, Opportunity in Brazilian Market Press

New ISR Report Uncovers Significant Clinical Development Activity, Opportunity in Brazilian Market

Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – February 20, 2014 – Industry Standard Research (ISR) released a new market research report this week entitled “Brazil: Clinical Development Country Profile.” The report provides insight into the clinical trial environment…
Jeremy Klein
ISR’s Brain Cancer (Glioblastoma Multiforme) Report Analyzes Market Opportunity, Product Pipelines Press

ISR’s Brain Cancer (Glioblastoma Multiforme) Report Analyzes Market Opportunity, Product Pipelines

Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – February 19, 2013 – Industry Standard Research (ISR) today announced the release of a new market research report titled “Brain Cancer (Glioblastoma Multiforme): Disease and Pipeline Analysis,” offering the…
Jeremy Klein
United Biosource Corporation (UBC) Receives High Marks for Staff Quality According to ISR Report Press

United Biosource Corporation (UBC) Receives High Marks for Staff Quality According to ISR Report

Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – January 6, 2013 – Industry Standard Research (ISR) has announced the availability of a new report titled “2013 CRO Quality Benchmarking – Phase IV Service Providers.”  This study surveyed…
Jeremy Klein
New ISR Report Uncovers Significant Clinical Development Activity, Opportunity in South Korean Market Press

New ISR Report Uncovers Significant Clinical Development Activity, Opportunity in South Korean Market

Informing the drug development and commercialization industry Cary, N.C. – June 27, 2013 – Industry Standard Research (ISR) released a new market research report this week entitled “South Korea: Clinical Development Country Profile.” The report provides insight into the clinical…
Jeremy Klein
ISR Reviews Report “Risk-based Monitoring: Industry Guidance on Adoption, Use, and Outsourcing” News

ISR Reviews Report “Risk-based Monitoring: Industry Guidance on Adoption, Use, and Outsourcing”

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s: ISR Reviews Report "Risk-based Monitoring: Industry Guidance on Adoption, Use, and Outsourcing" https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/ISR-Reviews-Report-Risk-based-Monitoring-Industry-/ArticleStandard/Article/detail/816364
Jeremy Klein
ISR Reports: Significant Opportunity Remains for Optimizing Clinical Trials by Using Electronic Medical Records Press

ISR Reports: Significant Opportunity Remains for Optimizing Clinical Trials by Using Electronic Medical Records

Informing the drug development and commercialization industry Cary, N.C. – June 20, 2013 – Industry Standard Research (ISR) today announced the release of a new market research report titled “EMRs and Clinical Research: Current and Potential Impact.” This report provides…
Jeremy Klein
ISR Report Provides Medical Device Industry with Analysis of Historical Trials, Development Market Size, and Manufacturer Profiles Press

ISR Report Provides Medical Device Industry with Analysis of Historical Trials, Development Market Size, and Manufacturer Profiles

Informing the drug development and commercialization industry Cary, N.C. – April 3, 2013 – Industry Standard Research (ISR) announced the release of a new market research report entitled “Medical Device: Clinical Development Market Assessment,” which provides the medical device industry…
Jeremy Klein
ISR in the News: 2013 Late Phase Market Overview and Outlook News

ISR in the News: 2013 Late Phase Market Overview and Outlook

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com's: "ISR Reports Breaks Down: 2013 Late Phase Market Overview and Outlook" https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/ISR-Reports-Breaks-Down-2013-Late-Phase-Market-Ove/ArticleStandard/Article/detail/807543
Jeremy Klein
ISR’s “Social Media: Best Practices and Strategic Use in Patient Recruitment” News

ISR’s “Social Media: Best Practices and Strategic Use in Patient Recruitment”

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com's: "ISR's 'Social Media: Best Practices and Strategic Use in Patient Recruitment'" https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/ISRs-Social-Media-Best-Practices-and-Strategic-Use/ArticleStandard/Article/detail/802212
Jeremy Klein
ISR’s Hepatitis C Market Analysis Shows a Deep Pipeline, Uncovers Lack of Internet Search Visibility for Current Therapies Press

ISR’s Hepatitis C Market Analysis Shows a Deep Pipeline, Uncovers Lack of Internet Search Visibility for Current Therapies

Informing the pharmaceutical and biotech industry. Cary, N.C. – October 9, 2012 – Industry Standard Research (ISR) today announced the availability of their latest report, “Hepatitis C: Social Media, Search, and Market Analysis,” providing a product and pipeline analysis of…
Jeremy Klein
Optimizing Investigator Fees News

Optimizing Investigator Fees

Normal 0 false false false EN-US X-NONE X-NONE ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com's: "Optimizing Investigator Fees" https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Data+Analysis/Optimizing-Investigator-Fees/ArticleStandard/Article/detail/800011 I’m not sure if it’s just me,…
Jeremy Klein
ISR Study Finds That INC Research Delivers CRO Industry’s Most Consistent Service Quality Press

ISR Study Finds That INC Research Delivers CRO Industry’s Most Consistent Service Quality

Informing the drug development and commercialization industry Cary, N.C. – February 28, 2012 – Industry Standard Research (ISR) today announced the availability of its 4th annual CRO Quality Benchmarking Report.  The 2012 version released Tuesday includes 125 pharmaceutical and biotechnology…
Jeremy Klein